Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #1120

    over 150.000 in the auction?

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #1121

      God morgen. 🙂

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #1122

        Asien: Stigninger på baggrund af optimisme og teknisk omlægning https://www.proinvestor.com/investornyt/675481/asien-stigninger-pa-baggrund-af-optimisme-og-teknisk-omlaegning-ny

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #1123

          Fredagens aviser med SAS, Matas og Novo Nordiskhttps://www.proinvestor.com/investornyt/675476/fredagens-aviser-med-sas-matas-og-novo-nordisk

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #1124

            STOCKHOLM (Nyhetsbyrån Direkt) Astra Zenecas Tagrisso (osimertinib) har blivit godkänt i EU för behandling av vuxna patienter i tidig fas av så kallad EGFR-muterad icke småcellig lungcancer.

            Det framgår av ett pressmeddelande.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #1125

              indicated for EGFRm patients whose tumours have exon 19 deletions or exon 21 (L858R) mutations. https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2021/tagrisso-approved-in-eu-in-early-lung-cancer.html

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #1126

                did we know this: KCR Cap
                @KcrCap

                $HALO has patent protection on ENHANZE through 2024 in Europe and 2027 in the US. Royalty rates drop by 50% upon patent expiration, but royalties can still be collected for 10 years following commercial launch https://twitter.com/KcrCap/status/1398041938645995520

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #1127

                  Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.17565

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1128

                    this is in Korean, from the Prof who will present on amivantamab at ASCO http://www.dreamdrug.com/Users/News/NewsView.html?ID=276681

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #1129

                      Langtidsoverlevelse forbedret i MM https://haematologisktidsskrift.dk/sygdomme/myeloma/846-langtidsoverlevelse-vokser-voldsomt-for-myelomatosepatienter.html

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Sukkeralf
                        wrote on sidst redigeret af
                        #1130

                        Link Preview Image
                        Bispecific antibodies in review: from cell line development to manufacturing

                        With the advent of a technology that targets two different epitopes simultaneously, growth in the global bispecific antibody market has accelerated in recent years. Dr Kevin Robinson spoke to Gregory Bleck, Vice President of Research and Development at Catalent Biologics, to discover more about the pros, cons and applications of these innovative therapies

                        favicon

                        (www.manufacturingchemist.com)

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Sukkeralf
                          wrote on sidst redigeret af
                          #1131

                          BsAbs view from Catalent Biologics:

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #1132

                            @Sukkeralf was there anything interesting in that Lava presentation?

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #1133

                              Early days so hard to say - but preclinically I think it looks very promising.

                              1 Reply Last reply
                              0
                              • S Offline
                                S Offline
                                Sukkeralf
                                wrote on sidst redigeret af
                                #1134

                                I would have loved to hear anything about their partnership with Janssen - but as usual you dont get any insight there

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1135

                                  ok. something to keep on the radar
                                  😉

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    Plimsoller
                                    wrote on sidst redigeret af
                                    #1136

                                    Så er vi tilbage til kursen ved årsskiftet 🙂

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      Mogan
                                      wrote on sidst redigeret af
                                      #1137

                                      Måske vi kan fejre nytårsaften i aften. I følge kursen, er det jo meget tæt på 31.december 2021 Genmab-tid.:-)

                                      1 Reply Last reply
                                      0
                                      • M Offline
                                        M Offline
                                        Mogan
                                        wrote on sidst redigeret af
                                        #1138

                                        To sjæle én tanke 🙂

                                        1 Reply Last reply
                                        0
                                        • nohopeN Offline
                                          nohopeN Offline
                                          nohope
                                          wrote on sidst redigeret af
                                          #1139

                                          Elendig udvikling i kursen, havde GEN bare fulgt OMXC25 de sidste 12 mdr. så havde den ligget i 2800.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger